Treatment with lenalidomide does not appear to increase the...

Haematologica 2012 / 02 Vol. 97; Iss. 2

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Ades, L., Le Bras, F., Sebert, M., Kelaidi, C., Lamy, T., Dreyfus, F., Eclache, V., Delaunay, J., Bouscary, D., Visanica, S., Turlure, P., Bresler, A. G., Cabrol, M.-P., Banos, A., Blanc, M., Vey, N.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
97
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2011.045914
Date:
February, 2012
File:
PDF, 269 KB
english, 2012
Conversion to is in progress
Conversion to is failed